首页> 外文期刊>Medical decision making: An international journal of the Society for Medical Decision Making >Validation of SURE, a four-item clinical checklist for detecting decisional conflict in patients
【24h】

Validation of SURE, a four-item clinical checklist for detecting decisional conflict in patients

机译:验证SURE(一项用于检测患者决策冲突的四项临床检查表)

获取原文
获取原文并翻译 | 示例
       

摘要

Background: We sought to determine the psychometric properties of SURE, a 4-item checklist designed to screen for clinically significant decisional conflict in clinical practice. Methods: This study was a secondary analysis of a clustered randomized trial assessing the effect of DECISION+2, a 2-hour online tutorial followed by a 2-hour interactive workshop on shared decision making, on decisions to use antibiotics for acute respiratory infections. Patients completed SURE and also the Decisional Conflict Scale (DCS), as the gold standard, after consultation. We evaluated internal consistency of SURE using the Kuder-Richardson 20 coefficient (KR-20). We compared DCS and SURE scores using the Spearman correlation coefficient. We assessed sensitivity and specificity of SURE scores (cut-off score ≤3 out of 4) by identifying patients with and without clinically significant decisional conflict (DCS score >37.5 on a scale of 0-100). Results: Of the 712 patients recruited during the trial, 654 completed both tools. SURE scores showed adequate internal consistency (KR-20 coefficient of 0.7). There was a significant correlation between DCS and SURE scores (Spearman's ρ = -0.45, P < 0.0001). The prevalence of clinically significant decisional conflict as estimated by the DCS was 5.2% (95% CI 3.7-7.3). Sensitivity and specificity of SURE ≤3 were 94.1% (95% CI 78.9-99.0) and 89.8% (95% CI 87.1-92.0), respectively. Conclusions: SURE shows adequate psychometric properties in a primary care population with a low prevalence of clinically significant decisional conflict. SURE has the potential to be a useful screening tool for practitioners, responding to the growing need for detecting clinically significant decisional conflict in patients.
机译:背景:我们试图确定SURE的心理测量特性,这是一个4项清单,旨在筛选临床实践中临床上重大的决策冲突。方法:本研究是对一项评估DECISION + 2效果的聚类随机试验的二级分析,DECISION + 2是一个2小时的在线教程,其后是一个2小时的互动式研讨会,旨在共同决策,决定使用抗生素治疗急性呼吸道感染。咨询后,患者完成了SURE,并且还制定了决策冲突量表(DCS)作为金标准。我们使用Kuder-Richardson 20系数(KR-20)评估了SURE的内部一致性。我们使用Spearman相关系数比较了DCS和SURE得分。我们通过识别有或没有临床上重大决策冲突(DCS评分> 37.5,等级为0-100)的患者,评估SURE评分(截止评分≤3/4)的敏感性和特异性。结果:在试验期间招募的712名患者中,有654名完成了这两种工具。 SURE分数显示出足够的内部一致性(KR-20系数为0.7)。 DCS和SURE得分之间存在显着相关性(Spearman的ρ= -0.45,P <0.0001)。 DCS估计临床上重大决策冲突的发生率为5.2%(95%CI 3.7-7.3)。 SURE≤3的敏感性和特异性分别为94.1%(95%CI 78.9-99.0)和89.8%(95%CI 87.1-92.0)。结论:SURE在初级保健人群中表现出足够的心理计量学特性,临床上具有重大决策冲突的患病率较低。 SURE有潜力成为从业者的有用筛查工具,可以满足对检测患者临床上重大决策冲突的日益增长的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号